Top-News

Essa Pharma Aktie News

Aktie
WKN:  A2JKQ4 ISIN:  CA29668H7085 US-Symbol:  EPIX Branche:  Biotechnologie Land:  Kanada
Keine aktuellen Kursdaten verfügbar
Depot/Watchlist
Marktkapitalisierung *
7,66 Mio. €
Streubesitz
20,68%
KGV
-
Dividende
1,69 $
Index-Zuordnung
-

Essa Pharma News

03.02.25 - PR Newswire
March 25, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against EPIX
March 25, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against EPIX PR Newswire
02.02.25 - PR Newswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma PR Newswire
31.01.25 - PR Newswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of ESSA Pharma Inc.(EPIX) Shareholders
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of ESSA Pharma Inc.(EPIX) Shareholders PR Newswire
30.01.25 - PR Newswire
EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit ...
30.01.25 - PR Newswire
Shareholders of ESSA Pharma Inc. Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - EPIX
Shareholders of ESSA Pharma Inc. Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - EPIX PR Newswire
28.01.25 - PR Newswire
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit PR Newswire
28.01.25 - PR Newswire
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
27.01.25 - PR Newswire
Stockholder Alert: Robbins LLP Informs Investors of the ESS Pharma Inc. Class Action
Stockholder Alert: Robbins LLP Informs Investors of the ESS Pharma Inc. Class Action PR Newswire
17.12.24 - PR Newswire
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +1,03%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »